ArticlePloS one2025
Effective SMOTE boost with deep learning for IDC identification in whole-slide images.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer is highlighted in recent research as one of the most prevalent types of cancer. Timely identification is essential for enhancing patient results and decreasing fatality rates. Utilizing computer-assisted detection and diagnosis early on may greatly improve the chances of recovery by accurately predicting outcomes and developing suitable treatment plans. Grading breast cancer properly, especially evaluating nuclear atypia, is difficult owing to faults and inconsistencies in slide preparation and the intricate nature of tissue patterns. This work explores the capability of deep learning to extract characteristics from histopathology photos of breast cancer. The research introduces a new method called SMOTE-based Convolutional Neural Network (CNN) technology to detect areas impacted by Invasive Ductal Carcinoma (IDC) in whole slide pictures. The trials used a dataset of 162 individuals with IDC, split into training (113 photos) and testing (49 images) groups. Every model was subjected to individual testing. The SMO_CNN model we developed demonstrated exceptional testing and training accuracies of 98.95% and 99.20% respectively, surpassing CNN, VGG19, and ResNet50 models. The results highlight the effectiveness of the created model in properly detecting IDC-affected tissue areas, showing great promise for improving breast cancer diagnosis and treatment planning. We surpassing other models as such, CNN, VGG19, ResNet50.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.